Literature DB >> 33051741

A Cost-Utility Analysis Comparing Immediate Oncoplastic Surgery with Delayed Oncoplastic Surgery in Smoking Breast Cancer Patients.

Joshua A Bloom1,2, Ammar Asban3, Tina Tian4, Yurie Sekigami4, Albert Losken5, Abhishek Chatterjee6.   

Abstract

BACKGROUND: Oncoplastic reduction mammoplasty for smoking breast cancer patients committed to smoking cessation may be performed immediately (increasing smoking-related risk) or in a delayed fashion (increasing radiation-related risk).
OBJECTIVE: Our aim was to examine the cost utility of immediate versus delayed oncoplastic reconstruction when operating on a smoking patient with breast cancer and macromastia with a long-term commitment to smoking cessation.
METHODS: A literature review determined the probabilities and outcomes for the treatment of unilateral breast cancer with immediate or delayed oncoplastic surgery. Reported utility scores were used to estimate quality-adjusted life-years (QALYs) for varying health states. A decision analysis tree was constructed with rollback analysis to highlight the more cost-effective strategy, and an incremental cost-utility ratio (ICUR) was calculated. Sensitivity analyses were performed to validate the robustness of the results.
RESULTS: Immediate oncoplastic surgery is associated with a higher clinical effectiveness (QALY) of 33.3 compared with delayed oncoplastic surgery (33.26), with a higher increment of clinical effectiveness of 0.07 and relative cost reduction of $3458.11. This resulted in a negative ICUR of -50,194, which favored immediate reconstruction, indicating a dominant strategy. In one-way sensitivity analyses, delayed reconstruction was the more cost-effective strategy if the probability of successful immediate reconstruction falls below 29% or its cost exceeds $29,611. Monte-Carlo analysis showed a confidence of 99% that immediate oncoplastic surgery is more cost effective.
CONCLUSIONS: Despite the risk of postoperative complications associated with smoking, immediate oncoplastic surgery is more cost effective compared with delayed oncoplastic surgery in which reconstructive surgery would occur after radiation.

Entities:  

Year:  2020        PMID: 33051741     DOI: 10.1245/s10434-020-09220-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  1 in total

Review 1.  Oncoplastic breast surgery: comprehensive review.

Authors:  N Bertozzi; M Pesce; P L Santi; E Raposio
Journal:  Eur Rev Med Pharmacol Sci       Date:  2017-06       Impact factor: 3.507

  1 in total
  1 in total

1.  The Impact of the COVID-19 Pandemic on Breast Reconstruction: A Canadian Perspective.

Authors:  Caroline F Illmann; Christopher Doherty; Margaret Wheelock; Joshua Vorstenbosch; Joan E Lipa; Toni Zhong; Kathryn V Isaac
Journal:  Plast Surg (Oakv)       Date:  2021-07-08       Impact factor: 0.947

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.